Patents by Inventor Ellie BEAMAN

Ellie BEAMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METASTATIC CANCER TREATMENT OR PREVENTION
    Publication number: 20230303672
    Abstract: The invention relates to agents which prevent or reduce the interaction between actin and one or more of its interacting partners, for use in treating or preventing metastatic cancer in a subject in need thereof. The invention also relates to a method of treating or preventing metastatic cancer, or a method of preventing or reducing epithelial cell to endothelial cell adhesion, comprising administering an agent which prevents or reduces the interaction between actin and one or more of its interacting partners.
    Type: Application
    Filed: August 13, 2021
    Publication date: September 28, 2023
    Applicant: OXFORD BROOKES UNIVERSITY
    Inventors: Susan BROOKS, David CARTER, Ellie BEAMAN
  • METASTATIC BIOMARKER
    Publication number: 20230305007
    Abstract: The invention relates to a method of determining whether a subject who has been diagnosed with cancer is likely to develop, or is likely to have developed, a metastasis, wherein the method comprises detecting the level of membrane-bound actin in a sample obtained from the subject. The invention also relates to methods and markers to diagnose, prognose, monitor and/or stage cancer, in particular metastatic cancer.
    Type: Application
    Filed: August 13, 2021
    Publication date: September 28, 2023
    Applicant: OXFORD BROOKES UNIVERSITY
    Inventors: Ryan PINK, Susan BROOKS, David CARTER, Ellie BEAMAN